Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Outlook January-September 2023 results on track to meet guidance for 2023 (organic1 ): • Revenues: "~4% growth” (+3.5% in 9M 23) • OIBDA: "~3% growth” (+2.6% in 9M 23) • CapEx to sales ratio of around 14% organic (13.4% in 9M 23)
Posted In: TEF